#Cancer Detection

Cyted Health Raises €37.5M Series B for Oesophageal Cancer Diagnostics

Cambridge-based Cyted Health secured €37.5 million in its Series B financing. EQT Life Sciences, Advent Life Sciences, and British Business Bank led the round.

Cyted Health Raises €37.5M Series B for Oesophageal Cancer Diagnostics

Cyted Health secured €37.5 million in Series B financing. EQT Life Sciences, Advent Life Sciences, and British Business Bank led the round. This funding will accelerate the company's US expansion for its oesophageal cancer diagnostics.

AI and the Transformation of the Medical World